Emmanouil Saloustros, President of the Board of Directors ΕΟΠΕ – HeSMO and Associate Professor of Oncology at University of Thessaly, shared a post by ΕΟΠΕ – HeSMO on LinkedIn, adding:
“Innovation in oncology is no longer the challenge. The real challenge is equal and timely access for patients.
With this in mind, ΕΟΠΕ – HeSMO, through the HeSMO Policy Office, organizes the conference on: ‘Pharmacoeconomics of Cancer: Innovation – Accessibility – Sustainability’.
Pharmacoeconomics is not a discussion about reducing spending. It’s a conversation about how we properly invest the available resources so that every patient has access to the best possible treatment, when they need it.
The sustainability of the health system cannot be achieved through control of expenditure alone. It requires investment in prevention, early diagnosis, biomarkers, precision medicine, real-world data and a comprehensive National Cancer Plan.
It is particularly important that representatives of the State, the academic community, patient associations and the pharmaceutical industry participate in the discussion. Addressing the challenges in oncology requires collaboration, evidence-based dialogue, and a shared vision.
The aim of the HeSMO Policy Office is to transform scientific knowledge into actionable policy proposals, contributing to the formation of a modern, sustainable and equitable oncology care system.
The debate on pharmaceutical economics is not just about numbers.
It’s about people.”
Quoting ΕΟΠΕ – HeSMO’s post:
“Cancer Pharmacoeconomics: Innovation, Accessibility, Sustainability
Access to innovative treatments for cancer patients is currently one of the biggest challenges for health systems.
On Saturday, June 20, 2026, at the Caravel Hotel, the Policy Office of the Hellenic Society of Medical Oncology (EOPE) is organizing its first Conference on the Pharmacoeconomics of Cancer and ensuring equal access to innovation.
With the participation of representatives of the State, the Pharmaceutical Industry, the Medical Community, Health Economics Experts and Patient Associations, the following will be discussed:
- Contemporary challenges in the availability of innovative cancer treatments
- The Impact of Restrictions on Patient Access
- Realistic and sustainable proposals for the future of oncology care in Greece
Our goal is to formulate a common roadmap that will ensure that no patient is deprived of the innovation offered by modern science.
For more information and the program.”
Other articles featuring Emmanouil Saloustros.